Nicholas J. MaragakisNicholas J. Maragakis

Nicholas J. Maragakis

Department of Neurology, Johns Hopkins University

Affiliated withJohns Hopkins University

Research Area

Neuroscience

Biography

Nicholas J. Maragakis has not added Biography.
If you are Nicholas J. Maragakis and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons
Publication title

Cited by 13

2021

Other Publications

Article
Year
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 11818550

2002
2002
2003
Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 12832537

2003
2004
2004
Glutamate transporters: animal models to neurologic disease.

Neurobiology of disease| PubMed ID: 15056453

2004
Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 15329404

2004
2004
2005
2006
2006
2006
Mechanisms of Disease: astrocytes in neurodegenerative disease.

Nature clinical practice. Neurology| PubMed ID: 17117171

2006
2007
2008
2008
Accurate ALSFRS-R scores can be generated from retrospective review of clinic notes.

Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases| PubMed ID: 18985465

2009
Rethinking a drug treatment failure on a traditional ALS target.

Experimental neurology| PubMed ID: 19309797

2009
2009
Advances in stem cell research for Amyotrophic Lateral Sclerosis.

Current opinion in biotechnology| PubMed ID: 19819686

2009
2010
Stem cells and the ALS neurologist.

Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases| PubMed ID: 20509745

2010
2011
2011
Stem cell transplantation for spinal cord neurodegeneration.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 21913120

2011
Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 21969586

2011
2011
2012
2012
Glia: an emerging target for neurological disease therapy.

Stem cell research & therapy| PubMed ID: 23021042

2012
2013
2013
2014
2014
2015
Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 25492561

2015
2015
2015
2015
2015
2015
2016
Hemiparetic Primary Lateral Sclerosis: Revisiting Mills Syndrome.

Case reports in neurology| PubMed ID: 26500542

2015
2016
2016
2016
Defining SOD1 ALS natural history to guide therapeutic clinical trial design.

Journal of neurology, neurosurgery, and psychiatry| PubMed ID: 27261500

2017
2017
2017
MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 28416596

2017
Motoneuron Disease: Basic Science.

Advances in neurobiology| PubMed ID: 28674981

2017
Motoneuron Disease: Clinical.

Advances in neurobiology| PubMed ID: 28674982

2017
What can we learn from the edaravone development program for ALS?

Amyotrophic lateral sclerosis & frontotemporal degeneration| PubMed ID: 28872911

2017
Erratum.

Advances in neurobiology| PubMed ID: 28905310

2017
2017
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis & frontotemporal degeneration| PubMed ID: 29191052

2018
2018
2018
2018
Olfactory dysfunction in amyotrophic lateral sclerosis.

Annals of clinical and translational neurology| PubMed ID: 30128322

2018
Current and emerging ALS biomarkers: utility and potential in clinical trials.

Expert review of neurotherapeutics| PubMed ID: 30273061

2018
2019
2019
2020
2020
Persistent Cyfip1 Expression Is Required to Maintain the Adult Subventricular Zone Neurogenic Niche.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 31988061

2020
2020
2020
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for ALS.

The New England journal of medicine| PubMed ID: 32640130

2020
2021
2021